Description

59,71,920 equity shares of BANDARAM PHARMA PACKTECH LIMITED listed on BSE at Rs. 20/- per share (including premium of Rs. 10/-) issued on preferential basis to promoters and non-promoters.

Summary

BSE has listed 59,71,920 new equity shares of BANDARAM PHARMA PACKTECH LIMITED (Scrip Code: 524602) with effect from December 16, 2025. The shares were issued on a preferential basis to promoters and non-promoters at Rs. 20/- per share (face value Rs. 10/- plus premium of Rs. 10/-). The allotment date was November 6, 2025, and the shares rank pari-passu with existing equity shares.

Key Points

  • Total shares listed: 59,71,920 equity shares of Rs. 10/- each
  • Issue price: Rs. 20/- (face value Rs. 10/- + premium Rs. 10/-)
  • Allotment basis: Preferential to promoters and non-promoters
  • Trading commencement: December 16, 2025
  • ISIN: INE875N01036
  • Distribution numbers: 12000001 to 17971920
  • Shares rank pari-passu with existing equity shares

Regulatory Changes

No regulatory changes. This is a standard listing notification for preferential allotment.

Compliance Requirements

Trading members must note the listing of these new securities and the applicable lock-in restrictions when processing trades.

Important Dates

  • Allotment Date: November 6, 2025
  • Trading Commencement: December 16, 2025
  • Lock-in Period 1: 22,54,484 shares (Dist. Nos. 12000001 - 14254484) locked until June 30, 2027
  • Lock-in Period 2: 37,17,436 shares (Dist. Nos. 14254485 - 17971920) locked until June 30, 2026

Impact Assessment

This is a routine corporate action with minimal market impact. The preferential allotment increases the paid-up capital of BANDARAM PHARMA PACKTECH LIMITED. Lock-in provisions ensure that a significant portion of the newly issued shares (all 59.71 lakh shares) cannot be traded immediately, with different lock-in periods applying to promoter and non-promoter categories. The staggered lock-in expiry dates (2026 and 2027) will gradually increase tradable float over time.

Impact Justification

Routine listing notification for preferential allotment affecting a single company with limited market-wide impact